Page last updated: 2024-12-10

bombykal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bombykal: from M. sexta; RN given refers to (Z,E)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5283378
SCHEMBL ID830539
SCHEMBL ID830541
MeSH IDM0182442

Synonyms (19)

Synonym
bombykal
LMFA06000094
10,12-hexadecadienal
63024-98-6
AKOS005145720
(10e,12e)-hexadeca-10,12-dienal
10,12-hexadecadienal, (10e,12e)-
69977-24-8
(e,e)-10,12-hexadecadienal
(10e,12e)-10,12-hexadecadienal
SCHEMBL830539
SCHEMBL830541
OSFASEAZCNYZBW-YTXTXJHMSA-N
(10e,12e)-10,12-hexadecadienal #
e,e-10,12-hexadecadienal
J-500103
(10e,12e)-hexadecadienal
(e,e)-10,12-hexadecadienal cas 69977-24-8
10e,12e-hexadecadienal

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"In extracellular tip recordings from long trichoid sensilla of male Manduca sexta moths, we studied dose-response relationships in response to bombykal stimuli of two different durations in the adapted and the non-adapted state."( Adaptation in pheromone-sensitive trichoid sensilla of the hawkmoth Manduca sexta.
Dolzer, J; Fischer, K; Stengl, M, 2003
)
0.52
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (7.69)18.2507
2000's11 (42.31)29.6817
2010's12 (46.15)24.3611
2020's1 (3.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.49 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index5.15 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]